TabletAnti Diabetic

Sitagliptin + Glimepiride

Sitagliptin + Glimepiride · DPP-4 inhibitor and sulfonylurea combination

TabletAnti Diabetic

Sitagliptin + GlimepirideProspero Healthcare

A tablet combining sitagliptin, a DPP-4 inhibitor, with glimepiride, a sulfonylurea that stimulates insulin release. It is used to improve glycaemic control in adults with type 2 diabetes mellitus.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sitagliptin + Glimepiride
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: DPP-4 inhibitor and sulfonylurea combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category

Tablet
Pioglitazone + Metformin
Pioglitazone + MetforminTablet
Tablet
Sitagliptin + Metformin + Glimepiride
Sitagliptin + Metformin + GlimepirideTablet
Tablet
Sitagliptin 25/50/100mg
Sitagliptin 25/50/100mgTablet
Tablet
Vildagliptin
VildagliptinTablet
Tablet
Dapagliflozin + Metformin
Dapagliflozin + MetforminTablet
Tablet
Dapagliflozin 5/10mg
Dapagliflozin 5/10mgTablet